These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22884627)

  • 1. Synthesis of cross-linked carboxyl poly(glycerol methacrylate) and its application for the controlled release of doxorubicin.
    Gu W; Ma Y; Zhu C; Chen B; Ma J; Gao H
    Eur J Pharm Sci; 2012 Oct; 47(3):556-63. PubMed ID: 22884627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carboxylated poly(glycerol methacrylate)s for doxorubicin delivery.
    Ma Y; Gao H; Gu W; Yang YW; Wang Y; Fan Y; Wu G; Ma J
    Eur J Pharm Sci; 2012 Jan; 45(1-2):65-72. PubMed ID: 22085680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained in vitro release and cell uptake of doxorubicin adsorbed onto gold nanoparticles and covered by a polyelectrolyte complex layer.
    Minati L; Antonini V; Torrengo S; Serra MD; Boustta M; Leclercq X; Migliaresi C; Vert M; Speranza G
    Int J Pharm; 2012 Nov; 438(1-2):45-52. PubMed ID: 22959992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Layer-by-layer supramolecular assemblies based on linear and star-shaped poly(glycerol methacrylate)s for doxorubicin delivery.
    Sun Y; Gao H; Yang YW; Wang A; Wu G; Wang Y; Fan Y; Ma J
    J Biomed Mater Res A; 2013 Aug; 101(8):2164-73. PubMed ID: 23281065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Block co-polymer nanoparticles with degradable cross-linked core and low-molecular-weight PEG corona for anti-tumour drug delivery.
    Abraham G; McCarroll J; Byrne F; Saricilar S; Kavallaris M; Bulmus V
    J Biomater Sci Polym Ed; 2011; 22(8):1001-22. PubMed ID: 20566070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of modified lipid nanoparticles for doxorubicin controlled release.
    Ying XY; Du YZ; Chen WW; Yuan H; Hu FQ
    Pharmazie; 2008 Dec; 63(12):878-82. PubMed ID: 19177903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic in vivo imaging of dual-triggered microspheres for sustained release applications: synthesis, characterization and cytotoxicity study.
    Efthimiadou EK; Tapeinos C; Chatzipavlidis A; Boukos N; Fragogeorgi E; Palamaris L; Loudos G; Kordas G
    Int J Pharm; 2014 Jan; 461(1-2):54-63. PubMed ID: 24286923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
    Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of complex nano-particles based on alginic acid/poly[(2-dimethylamino) ethyl methacrylate] and a drug vehicle for doxorubicin release controlled by ionic strength.
    Cai H; Ni C; Zhang L
    Eur J Pharm Sci; 2012 Jan; 45(1-2):43-9. PubMed ID: 22079138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro release behavior of dextran-methacrylate hydrogels using doxorubicin and other model compounds.
    Kim SH; Chu CC
    J Biomater Appl; 2000 Jul; 15(1):23-46. PubMed ID: 10972158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosslinked biomimetic random copolymer micelles as potential anti-cancer drug delivery vehicle.
    Zhang J; Gong M; Yang S; Gong YK
    J Control Release; 2011 Nov; 152 Suppl 1():e23-5. PubMed ID: 22195875
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis, self-assembly, and in vitro doxorubicin release behavior of dendron-like/linear/dendron-like poly(epsilon-caprolactone)-b-poly(ethylene glycol)-b-poly(epsilon-caprolactone) triblock copolymers.
    Yang Y; Hua C; Dong CM
    Biomacromolecules; 2009 Aug; 10(8):2310-8. PubMed ID: 19618927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triply triggered doxorubicin release from supramolecular nanocontainers.
    Loh XJ; del Barrio J; Toh PP; Lee TC; Jiao D; Rauwald U; Appel EA; Scherman OA
    Biomacromolecules; 2012 Jan; 13(1):84-91. PubMed ID: 22148638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release.
    Zheng Q; Lin T; Wu H; Guo L; Ye P; Hao Y; Guo Q; Jiang J; Fu F; Chen G
    Int J Pharm; 2014 Mar; 463(1):22-6. PubMed ID: 24393764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversibly crosslinked poly(vinyl alcohol) nanoparticles for triggered release of doxorubicin.
    Li Y; Wei R; Ji S; Meng F; Zhong Z
    J Control Release; 2011 Nov; 152 Suppl 1():e54-5. PubMed ID: 22195923
    [No Abstract]   [Full Text] [Related]  

  • 16. Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin.
    Talelli M; Iman M; Varkouhi AK; Rijcken CJ; Schiffelers RM; Etrych T; Ulbrich K; van Nostrum CF; Lammers T; Storm G; Hennink WE
    Biomaterials; 2010 Oct; 31(30):7797-804. PubMed ID: 20673684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.
    Zhang J; Chen XG; Li YY; Liu CS
    Nanomedicine; 2007 Dec; 3(4):258-65. PubMed ID: 17962086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Acetyl-D-glucosamine decorated polymeric nanoparticles for targeted delivery of doxorubicin: Synthesis, characterization and in vitro evaluation.
    Tian B; Ding Y; Han J; Zhang J; Han Y; Han J
    Colloids Surf B Biointerfaces; 2015 Jun; 130():246-54. PubMed ID: 25921641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifunctional hollow nanoparticles based on graft-diblock copolymers for doxorubicin delivery.
    Lu PL; Chen YC; Ou TW; Chen HH; Tsai HC; Wen CJ; Lo CL; Wey SP; Lin KJ; Yen TC; Hsiue GH
    Biomaterials; 2011 Mar; 32(8):2213-21. PubMed ID: 21176954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy.
    Ko J; Park K; Kim YS; Kim MS; Han JK; Kim K; Park RW; Kim IS; Song HK; Lee DS; Kwon IC
    J Control Release; 2007 Nov; 123(2):109-15. PubMed ID: 17894942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.